EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Proteomic and bioinformatics analyses on the protective mechanisms of scutellarin in diabetic retinopathy

Yan-Ping Qian, Yi-Jian Sun, Song-Lin Zhu, Guo-Xing Zhang, Jia-Wei Zhang, Ping Chang, Na Li

New Medicine · 2026-06 · 4 (2) · 85-93

DOI: 10.1097/nm9.0000000000000003 ↗

Kurz gefasst

Fachartikel in der Zeitschrift New Medicine, online erschienen am 07.07.2026. Verfasst von Yan-Ping Qian und 6 weiteren Autor:innen. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The aim of this study was to investigate the protective mechanisms of scutellarin against diabetic retinopathy (DR).

Methods

Thirty male Sprague-Dawley rats were randomized into control (CON), diabetes mellitus (DM), and scutellarin (SCU)-treated groups (n = 10 each). Type 1 diabetes was induced by intraperitoneal streptozotocin (55 mg/kg; fasting glucose ≥16.7 mmol/L). After 6 weeks, the SCU group received daily intraperitoneal scutellarin (50 mg/kg) for 4 weeks, while CON and DM groups received saline. Retinal morphology was assessed by optical coherence tomography. Differentially expressed proteins were identified by 4D data-independent acquisition proteomics, followed by Venn analysis, hierarchical clustering, protein-protein interaction (PPI) analysis, Gene Ontology and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment, and molecular docking. Mylpf expression was validated by quantitative real-time polymerase chain reaction.

Results

Optical coherence tomography showed that scutellarin partially restored retinal thickness and attenuated DR-induced structural damage. Four intersecting differentially expressed proteins were identified among the groups: Col6a1, CPT1B, Mylpf, and Aspn. No direct PPI interactions were found among them, although indirect associations were revealed by network expansion. CPT1B, Mylpf, and Aspn were upregulated in DM rats and markedly downregulated after scutellarin treatment. Molecular docking demonstrated that only Mylpf exhibited a stable binding interaction with scutellarin. Gene Ontology and KEGG enrichment analyses indicated that these proteins were primarily enriched in focal adhesion and extracellular matrix-receptor interaction pathways. Real-time polymerase chain reaction confirmed that Mylpf messenger RNA expression was significantly upregulated in the DM group and subsequently downregulated after scutellarin treatment.

Conclusion

Scutellarin protects against DR, with Mylpf identified as a potential key target based on molecular docking and expression validation.

Zitieren

APA

Qian, Y., Sun, Y., Zhu, S., Zhang, G., Zhang, J., Chang, P., & Li, N. (2026). Proteomic and bioinformatics analyses on the protective mechanisms of scutellarin in diabetic retinopathy. New Medicine, 4(2), 85-93. https://doi.org/10.1097/nm9.0000000000000003

Vancouver

Qian Y, Sun Y, Zhu S, Zhang G, Zhang J, Chang P, et al. Proteomic and bioinformatics analyses on the protective mechanisms of scutellarin in diabetic retinopathy. New Medicine. 2026;4(2):85-93. doi:10.1097/nm9.0000000000000003

BibTeX
@article{Qian2026,
  author = {Qian, Yan-Ping and Sun, Yi-Jian and Zhu, Song-Lin and Zhang, Guo-Xing and Zhang, Jia-Wei and Chang, Ping and Li, Na},
  title = {Proteomic and bioinformatics analyses on the protective mechanisms of scutellarin in diabetic retinopathy},
  journal = {New Medicine},
  year = {2026},
  volume = {4},
  number = {2},
  pages = {85--93},
  doi = {10.1097/nm9.0000000000000003}
}
Kostenlos starten →